A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis.
about
TMC207: the first compound of a new class of potent anti-tuberculosis drugsBedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?Mechanisms of Pyrazinamide Action and ResistanceA Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant TuberculosisNew drugs to treat multidrug-resistant tuberculosis: the case for bedaquilineThe chemical biology of new drugs in the development for tuberculosis.Animal welfare in studies on murine tuberculosis: assessing progress over a 12-year period and the need for further improvement.Activities of TMC207, rifampin, and pyrazinamide against Mycobacterium tuberculosis infection in guinea pigs.Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis.Current development and future prospects in chemotherapy of tuberculosisPharmacokinetics and pharmacodynamics of TMC207 and its N-desmethyl metabolite in a murine model of tuberculosis.Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical modelsUsing Chemical Reaction Kinetics to Predict Optimal Antibiotic Treatment Strategies.Pyrazinamide may improve fluoroquinolone-based treatment of multidrug-resistant tuberculosis.New drugs and regimens for treatment of TB.New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.Update in tuberculosis 2008.Update in tuberculosis 2009.Emerging drugs for the treatment of tuberculosis.Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.Bedaquiline for the treatment of drug-resistant tuberculosis.Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects.The diarylquinoline R207910 is bactericidal against Mycobacterium leprae in mice at low dose and administered intermittently.Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.Once-weekly treatment of tuberculosis with the diarylquinoline R207910: a real possibility.Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?
P2860
Q24632091-47702F03-F68C-4C22-B27E-98B286077034Q26824413-018480C7-5520-433D-B84D-744050A0EE75Q29304444-F9B8D98D-34B2-4C7E-80D0-03DBD2D4DAB0Q33939074-6ABF043B-65FE-4B17-ACF5-9338BE91F724Q34005593-F35D2AA6-E978-4D73-B33D-18076544018CQ34054325-5EBA9138-0049-4E46-9B8B-99ED83ABFE7BQ34460532-CAE4D929-8D80-4982-9B73-266F6AEF9142Q34483596-514DA896-DC1F-4F50-88FE-CCF81BA20EADQ34737143-28C154C9-EB1E-462A-BB21-A93997B99DCDQ35705874-02068798-D703-47E5-99DF-2AD4CC4D4604Q35806445-CAF36AD2-C20C-4349-B315-0868112133FDQ36158384-EBB9A35B-E74F-455F-B638-C2CE9B28D44DQ36242447-FA48C0D4-D89F-45A5-8FAA-8AF22CAF26F8Q36364095-BAE663B2-5786-40C1-BB68-60D481F9F5A3Q36825354-1143B77E-C2C2-4DE1-8C94-AA765B39E8B3Q37346929-EDEF0A60-922C-43FC-B863-6B0F0ABD29B6Q37398528-4A65AEFE-AD26-43E5-AD2C-D03DEC186473Q37704062-04BCA026-DF26-4BE3-B864-653E69ED15A1Q37792105-7E6D4F93-4BAD-4141-A01B-F43DA8FBB127Q38040155-91EE03B3-38D8-43C1-8B51-D95BE351681DQ38386950-2ABE96C5-8FBB-4743-8338-D792AF714C06Q39967041-F1D05369-9DAF-4F5C-9316-8F1037DE75D2Q41940210-CF2A0B8C-0A1D-41DF-A41A-2426661EA401Q45933567-70A5C65C-9FC6-4B80-9E4D-F99F65898DD5Q46189388-7F9FF5B4-3CC8-4B85-9472-2C745BD20165Q47332682-C4485858-5863-4349-9E19-2368B4E035DB
P2860
A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A once-weekly R207910-containi ...... egimen in murine tuberculosis.
@ast
A once-weekly R207910-containi ...... egimen in murine tuberculosis.
@en
type
label
A once-weekly R207910-containi ...... egimen in murine tuberculosis.
@ast
A once-weekly R207910-containi ...... egimen in murine tuberculosis.
@en
prefLabel
A once-weekly R207910-containi ...... egimen in murine tuberculosis.
@ast
A once-weekly R207910-containi ...... egimen in murine tuberculosis.
@en
P2093
P2860
P1476
A once-weekly R207910-containi ...... egimen in murine tuberculosis.
@en
P2093
Aurelie Chauffour
Chantal Truffot-Pernot
Koen Andries
Murad Ibrahim
Nacer Lounis
Vincent Jarlier
P2860
P356
10.1164/RCCM.200711-1736OC
P407
P577
2008-10-23T00:00:00Z